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Purpose: We report a clinical case and present a brief review of the literature of peripheral
primitive neuroectodermal tumour (PNET) as a rare disease. We discuss the difﬁcult clinical
and pathological diagnosis and the multidisciplinary approach to treatment of PNET. We
debate radiosensitivity of extracranial recurrent retroperitoneal PNET.
Methods and materials: External beam radiation therapy was applied for a non-resectable
local recurrence of retroperitoneal PNET in a 74-year-old woman. There were no distant
metastases and our patient has refused chemotherapy.
Results: Local tumour control (LTC) was achieved after administration of a total dose of 60Gy
in 30 fractions by external beam 60 Cobalt radiotherapy.Conclusions: PNET is an aggressive malignant tumour inﬁltrating lymphatics and metas-
tasizing haematogenously. It requires a multimodality treatment. Late local recurrence of
extracranial retroperitoneal PNET has shown high radiosensitivity, so local tumour irradia-
tion could be a radical treatment even in non-resectable cases.
© 2009 Wielkopolskie Centrum Onkologii. Published by Elsevier Urban & Partner Sp. z.o.o.
All rights reserved.. Introduction
xtracranial PNET is a rare disease with fast and inﬁltrating
rowth. In the past PNET was called neuroepithelioma. It is
lassiﬁed today as a neoplasm with neuroperipheral origin.1
he tumour shows a very interesting histology. Extraosseous
eoplasm, including Ewing sarcoma, was described ﬁrst by
eft et al. in 1969.2 PNET consists of small, round cells
nd has Homer-Wright rosettes. After clinical observations
n non-differentiated brain tumours (consisting of 90–95%
on-differentiated cells) Hart and Earle in 1973 deﬁned such
umour similarly to primitive neuroectodermal neoplasm.
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might be called PNET despite different tumour localization.3
TheWHOclassiﬁcation considers it “embryonal-like tumours”
and PNET is a generic name for medulloblastoma.4 Ewing sar-
coma and PNET have similar pathomorphological character-
istics, prognosis, immunohistochemistry and cytogenetics.5
Extracranial peripheral PNET can be found in dif-
ferent body sites. Many authors have reported PNET
in the nasal cavity,6 maxilla,7,8 orbit,9 heart,10 kidney,11
adrenal glands,12 retroperitoneum,13 ovary,14,15 cervix,5,16,17
uterus,18–20 broad ligament of the body of the uterus,21
vulva, vagina and septum rectovaginalis,22–26 thoracic region
27 28,29(Askin’s tumour), extremities, etc. Routine use of
immunohistochemistry and electronic microscopy facilitate
diagnosis of peripheral PNET, so more and more cases are
published.1
Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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Fig. 2 – CT of retroperitoneal PNET recurrence.Fig. 1 – Poorly to well formed rosettes.
2. Case report
We present a 74-year-old woman with retroperitoneal PNET
diagnosed in 2001. In 2001 a maximal tumour resection (R1)
was carried out. The patient refused any adjuvant chemother-
apy and radiotherapy. Seven months later a second operation
was performed because of growing tumour mass. Radical sur-
gical resection (R0) was done. A non-resectable local relapse
without distant metastasis occurred after 4 years’ remission
(2006). External beam radiation therapy with mainly analgesic
intent was performed.
Preoperative ﬁnding (2001): A large tumour mass with a size
of 10/15 cm was palpated in the abdominal area.
Intraoperative observation (2001):A large tumour mass with a
size of 13/16 cmwas found sited in the retroperitoneum, push-
ing off the pancreas, duodenum and transverse colon. The
formation grewout to the radixmesenterii and theduodenum,
as well as to the vena cava inferior.
Intraoperative (second operation after 7 months—2002): The
tumour mass started from the hilus of the right kidney, reach-
ing deep into the intervertebral space, and grew out close to
the vena renalis and vena cava inferior.
Histology and immunohistochemistry: The tumour consists of
small, round cells, with poorly to well-formed rosettes. The
diagnosis was primitive malignant tumour with MIC2 gene
expression (Fig. 1).
Chest X-ray, ultrasound of abdomen, bone scan and CT of
brain showed no distant metastasis.
CT of abdomen (06.2006—before irradiation). There is no
ascites. Liver, gall-bladder, pancreas and spleen have normal
size and structure. A large lobulated parenchymal tumour
mass was registered in the prevertebral space starting from
the level of the lower posterior mediastinum and it was
traced retroperitoneally to the level of the aortic bifurcation.
The mainly homogeneous look of the structure after contrast
enhances its density and reveals peripheral hypodense zones,
suggesting necrosis.
The mass embraces like a muff the large retroperitoneal
vessels, the main branches of the abdominal aorta at the level
of the kidney artery, inﬁltrating the intraperitoneal space, and
invades the right iliopsoas muscle. Both kidneys are of normal
size and excrete symmetrically without drainage dysfunc-tion. The CT diagnosis was retroperitoneal tumour recurrence
(Fig. 2).
2.1. Radiotherapy
The retroperitoneal space was initially irradiated on a mega-
voltage machine (Cobalt 60) with single fractions of 2Gy to
a total dose of 44Gy. Because the palliative analgesic effect
was achieved, it was decided that the boost dose should be
applied. The retroperitoneal space with the proximity of kid-
neys, spinal cord and liver is a difﬁcult area for irradiation, so
we delivered the maximum possible total dose of 60Gy.
2.1.1. Follow-up investigations
CT of abdomen (2months after the end of the radiotherapy). There is
no ascites. Liver, gall-bladder, pancreas and spleen appear to
have standard size and structure. Both kidneys are of normal
size and excrete symmetrically without drainage dysfunc-
tions. No enlarged lymph nodes were revealed.
Compared to the previous CT, no retroperitoneal mass is
scanned. Thickened soft tissues are found in the right prever-
tebral space at the level of L1–2; after contrasting no change
in the density was established. Blurred lateral delineations of
the right psoas muscle were noted.
2.1.2. Conclusion
CT diagnosis was ﬁbrosis (Fig. 3).Fig. 3 – CT scans after the application of the total
irradiation dose of 60Gy. Local tumour control achieved.
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. Discussion
literature review demonstrates that retroperitoneal PNET is
group of heterogeneous tumours including peripheral PNET
nd retroperitoneal non-differentiated sarcoma. We discuss a
ew major points of the problem:
1) Difﬁcult diagnosis of PNET. Using only anamnesis and imag-
ing modalities it is impossible to obtain the diagnosis
preoperatively.12 The pathohistological diagnosis is difﬁ-
cult.
Differential diagnosis includes many tumour entities such
as primary small cell tumour, Wilms’ tumour, carcinoid
tumour, rhabdomyosarcoma, neuroblastoma, osteosar-
coma, non-Hodgkin lymphoma, malignant melanoma
and metastasis.30 Immunohistochemistry and electron
microscopy examinations are required. It refers to imma-
ture primitive malignant tumour, expressing the MIC2
gene, proved by the marker CD99.15,31 Homer-Wright
(H-W) rosettes are often found.32 Cells seen on elec-
tron microscopic examination are characterized by small
amounts of mitochondria and glycogen particles without
neurosecretory granules.5,32
2) Optimal treatment of PNET. There are no standard guidelines
or diagnosis and treatment of peripheral PNET, because
of the small number of cases in different body sites.33
Extraosseous PNETs are more aggressive, with worse prog-
nosis than bone PNET (Ewing’s sarcoma), and thus require
multimodal treatment.34,35 It has a trend to relapse locally,
and to develop metastasis in the regional lymph nodes,
lung, liver and bones.5 Prognostic factors are based on the
tumour stage, grade, patient’s age, extent of the surgery,
surgical margin status, treatment beginning time, etc.
Some authors have reported about chemotherapy for
six weeks before or after surgery or radiotherapy.13
Chemotherapy protocols for Ewing’s sarcoma could
be useful. PNET has also shown sensitivity to other
chemotherapy regimens–ifosfamide, etoposide, tenipo-
side and cisplatin.29,33 In our case the patient has
absolutely refused postoperative chemotherapy.
After biopsy or R1–R2 surgery radiotherapy to a total dose
of 55–60Gy is required.13,36 Previous studies on combined
treatment (surgery, radiotherapy and chemotherapy) of
PNET have shown that this is a radio- and chemosen-
sitive immature embryonic tumour. The observations
and clinical experience demonstrate moderate radio- and
chemosensitivity. Four to six cycles of doxorubicin and
cyclophosphamide, radical surgery and irradiation lead
to remission and dramatic tumour reduction.37 Because
of the sporadic nature of cases, both chemotherapy
regimens1 and total dose of irradiation are still not speci-
ﬁed. Intensive follow-up with CT or MRI of abdomen and
retroperitoneum every 6 months is needed.
3) Radiosensitivity of late local PNET relapses. Published data for
PNET illustrate odd tumour characteristics to recur after
2–5 years, or even after 15 years.38 We are presenting the
current case of extracranial retroperitoneal PNET not only
because of the casuistry, but as a case of rare late only local
relapse, without distant metastasis. Although the recur-therapy 1 4 ( 2 0 1 0 ) 221–224 223
rent tumour was aggressive, spreading over the adjacent
major vessels and nerves, it was totally controlled after a
total dose of 60Gy. Our results support the thesis of mod-
erate to high PNET radiosensitivity and demonstrate the
possibility to control even non-resectable advanced cases
by radical radiation doses.
4. Conclusions
1. PNET is an aggressive, immature embryonic radiosensitive
tumour that tends to recur locally and to metastasize.
2. Retroperitoneal PNET is a radiosensitive tumour, for which
the application of radical doses is recommended even in
the case of non-resectable recurrence.
3. The biological behaviour of PNET predetermines the late
local relapses. This requires multimodality treatment with
surgery, radiotherapy and chemotherapy.
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